All data are based on the daily closing price as of April 2, 2025
v

Vuno

338220.KQ
16.83 USD
-0.52
-3.00%

Overview

Last close
16.83 usd
Market cap
233.75M usd
52 week high
35.85 usd
52 week low
15.52 usd
Target price
27.71 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
19.8896
Price/Book Value
55.8654
Enterprise Value
238.40M usd
EV/Revenue
14.5107
EV/EBITDA
-9.7142

Key financials

Revenue TTM
11.80M usd
Gross Profit TTM
11.10M usd
EBITDA TTM
-9.57M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
20.10M usd
Net debt
3.66M usd

About

Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system. The company was founded in 2014 and is headquartered in Seoul, South Korea.
  • Symbol
    338220.KQ
  • Exchange
    KQ
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Health Information Services
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.vuno.co
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top